BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33239504)

  • 21. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.
    Inamura K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting.
    Kapur P; Brugarolas J; Trpkov K
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillary renal cell carcinoma with extensive spindle cell foci: mimicker of mucinous tubular and spindle cell carcinoma.
    Rajack F; Medford S; Naab T
    Autops Case Rep; 2024; 14():e2024479. PubMed ID: 38487036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma.
    Purdue MP; Rhee J; Moore L; Gao X; Sun X; Kirk E; Bencko V; Janout V; Mates D; Zaridze D; Petruzella S; Hakimi AA; Linehan WM; Chanock SJ; Brennan P; Furberg H; Troester M; Rothman N
    Int J Cancer; 2021 Oct; 149(7):1448-1454. PubMed ID: 34058014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New Entities.
    Sanguedolce F; Mazzucchelli R; Falagario UG; Cormio A; Zanelli M; Palicelli A; Zizzo M; Eccher A; Brunelli M; Galosi AB; Carrieri G; Cormio L
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A young female patient with multiple unilateral low-grade oncocytic renal tumors and angiomyolipoma: a case report and literature review.
    Xu Y; Jiang X; Meng H
    J Surg Case Rep; 2024 Mar; 2024(3):rjae125. PubMed ID: 38524677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low grade oncocytic renal tumor: A case report.
    Zhang M; Tian H; Wang Q; Xing C
    Asian J Surg; 2024 May; ():. PubMed ID: 38806358
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Williamson SR; Gill AJ; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Hes O
    Mod Pathol; 2021 Jun; 34(6):1167-1184. PubMed ID: 33526874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma.
    Lang M; Vocke CD; Ricketts CJ; Metwalli AR; Ball MW; Schmidt LS; Linehan WM
    Urology; 2021 Mar; 149():89-97. PubMed ID: 33242557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear Cell Tumor With Melanocytic Differentiation and ACTIN-MITF Translocation: Report of 7 Cases of a Novel Entity.
    de la Fouchardiere A; Pissaloux D; Tirode F; Karanian M; Fletcher CDM; Hanna J
    Am J Surg Pathol; 2021 Jul; 45(7):962-968. PubMed ID: 33264137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
    Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic and phenotypic heterogeneity in prostate cancer.
    Haffner MC; Zwart W; Roudier MP; True LD; Nelson WG; Epstein JI; De Marzo AM; Nelson PS; Yegnasubramanian S
    Nat Rev Urol; 2021 Feb; 18(2):79-92. PubMed ID: 33328650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of tyrosine kinase receptor B and brain-derived neurotrophic factor expression in salivary duct carcinoma.
    Kondo Y; Hirabayashi K; Carreras J; Tsukinoki K; Ota Y; Okami K; Nakamura N
    Ann Diagn Pathol; 2021 Feb; 50():151673. PubMed ID: 33248386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Biomarker Testing in Localized Prostate Cancer: The Critical Role of Pathologists.
    Baraban E; Netto G; Ventura CB; Zhou M
    Arch Pathol Lab Med; 2021 Mar; 145(3):264-265. PubMed ID: 33351911
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical deployment of AI for prostate cancer diagnosis.
    Janowczyk A; Leo P; Rubin MA
    Lancet Digit Health; 2020 Aug; 2(8):e383-e384. PubMed ID: 33328042
    [No Abstract]   [Full Text] [Related]  

  • 36. Mesonephric (Wolffian-derived) Adenocarcinoma of the Female Urethra.
    Paner GP; Lopez-Beltran A; Amin MB
    Am J Surg Pathol; 2021 Apr; 45(4):543-549. PubMed ID: 33284194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
    Zou Q; Zhang L; Cheng Z; Guo X; Cao D
    Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of testicular function and spermatogenesis in transgender women.
    Vereecke G; Defreyne J; Van Saen D; Collet S; Van Dorpe J; T'Sjoen G; Goossens E
    Hum Reprod; 2021 Jan; 36(1):5-15. PubMed ID: 33257947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey.
    Akgul M; Williamson SR; Ertoy D; Argani P; Gupta S; CaliĆ² A; Reuter V; Tickoo S; Al-Ahmadie HA; Netto GJ; Hes O; Hirsch MS; Delahunt B; Mehra R; Skala S; Osunkoya AO; Harik L; Rao P; Sangoi AR; Nourieh M; Zynger DL; Smith SC; Nazeer T; Gumuskaya B; Kulac I; Khani F; Tretiakova MS; Vakar-Lopez F; Barkan G; MoliniĆ© V; Verkarre V; Rao Q; Kis L; Panizo A; Farzaneh T; Magers MJ; Sanfrancesco J; Perrino C; Gondim D; Araneta R; So JS; Ro JY; Wasco M; Hameed O; Lopez-Beltran A; Samaratunga H; Wobker SE; Melamed J; Cheng L; Idrees MT
    J Clin Pathol; 2021 May; 74(5):291-299. PubMed ID: 33514585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive low-grade papillary urothelial carcinoma with degenerative nuclear atypia: a grading pitfall.
    Matoso A; Parimi V; Epstein JI
    Hum Pathol; 2021 Jul; 113():1-8. PubMed ID: 33887303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.